JPML Centralizes Insulin Price-Fixing Suits In New Jersey
Law 360
AUGUST 4, 2023
The Joint Panel of Multidistrict Litigation has sent five state cases against insulin manufacturers such as Eli Lilly and pharmacy benefit managers including CVS to the District of New Jersey, ruling the district will allow for efficient pretrial proceedings.
Let's personalize your content